Background: Limited data are available about the accuracy of postexposure prophylaxis (PEP) prescription in the emergency rooms. Here, we evaluated PEP prescription decision making with respect to the risk of sexual HIV transmission and the exposed person's fear vis-à-vis HIV.
INTRODUCTION
Preventing HIV transmission is a major public health challenge. 1 Combined antiretroviral therapy (cART) is a valuable tool in this effort, either as preexposure (PrEP) 2 or postexposure prophylaxis (PEP). 3 PEP is highly effective in nonhuman primates in reducing the risk of simian immunodeficiency virus transmission by 77%-95%. 4 The main factors determining its effectiveness are the lag time between exposure and start of cART and its duration of intake. 4, 5 In humans, PEP with Zidovudine alone reduced the risk of HIV transmission by 80% after occupational exposure. 6 In 1997, the Swiss Federal Office of Public Health (FOPH) recommended PEP after an HIV sexual risk exposure. 7 After the introduction of cART by end of the 1990s, it was controversial whether PEP should be prescribed in nonoccupational (sexual) contacts. [8] [9] [10] Today, according to the European AIDS Clinical Society guideline 11 and the FOPH guideline updated in 2006, 12 PEP is primarily recommended for persons having unprotected sex (ie, anal, vaginal, or receptive oral sex with ejaculation) with a viremic HIVpositive partner or a partner with unknown serostatus but with the presence of HIV risk factors [ie, men who have sex with men (MSM), sex workers, intravenous drug users (IDU), or persons from a country with a high HIV prevalence]. PEP is not recommended for persons having unprotected sex with an HIV-infected partner on successful cART. In all other situations with unprotected sex, individual risk should be evaluated. The internal guidelines from the University Hospital Zurich (USZ), relevant to the analyzed period, were largely derived from the FOPH guideline but left a lot of room for subjective risk evaluation by the physician, stating that:
PEP should be prescribed in the following situations: unprotected vaginal, anal, or oral receptive intercourse with an HIV-positive partner or during menstruation. PEP should not be prescribed in cases of unprotected intercourse with a partner with unknown HIV status. In this case, fears and needs of the exposed person should be taken into account. Neither categorical nonprescription nor uncritical prescription can be encouraged.
Previous studies have already shown that the decision to use PEP is influenced by the experience of the physician in charge, 10 the emergency room (ER) setting, 8 and the exposed person's request. 10 Notwithstanding, people taking PEP frequently suffer from side effects that result in poor adherence, and as a result, only 65%-78% finish the 4-week PEP regimen. 13, 14 Thus, the physician in charge must weigh the pros and cons of PEP carefully in each case.
Here we systematically assessed PEP decision making and factors that influence PEP decision making in daily practice in a large ER of a tertiary care hospital. Identifying these factors would be a major step in optimizing decision making. We retrospectively evaluated all persons seeking advice on PEP at the ER of the USZ between 2007 and 2013. We then reviewed whether the decision making was in agreement with a risk assessment algorithm for PEP prescription. In particular, we collected data on the demographic factors of the persons, the kind of sexual risk taken, the experience of the ER physician, and eventually the person's request and correlated these data with the evaluated decisions.
METHODS

Ethics
The study was approved by the Institutional Review Board of the USZ (KEK-ZH-Nr. 2013-0006).
Study Design
We identified, in a retrospective and cross-sectional manner, all persons admitted to the ER of the USZ seeking advice for HIV PEP in 2007-2013 by screening all electronic charts from that period for the following keywords: postexposure prophylaxis, PEP, risk, exposure, sexual intercourse, and sex. Nonconsensual sex and occupational HIV exposure were excluded from the analysis. This ER has ;17,000 general internal medicine consultations per year.
Demographic Data and Sexual History
We collected the following data from the identified electronic charts for each exposed person: (1) demographic data, (2) a detailed sexual history, including type of sexual intercourse [ie, insertive, receptive, versatile (insertive and receptive), anal, vaginal, oral, smear of body fluids on healthy or wounded skin or mucous membranes, hand/feet to genitals contact, condom use, condom dysfunction], hours since exposure, or additional risk factors for HIV transmission (ie, menstruation, ejaculation, and sexually transmitted infections), and (3) the result from the HIV screening test at presentation. Based on the retrospective nature of the study, it was not possible to define oral sex with or without sperm exchange; thus, we considered unprotected oral sex as a risk situation. By default, every person seeking PEP at the ER should be tested for HIV on the spot. This screening was done with the fourth generation HIV antigen/antibody (Ag/Ab) combo screening test (Abbot, Wiesbaden, Germany), and its result should be available by 4 hours at the latest. Furthermore, for each source partner, we collected the gender, the risk group (ie, MSM, sex worker, from endemic country, IDU), last known HIV status, and the result of the HIV screening test performed at the ER if he presented together with the exposed person. If the presenting source partner was already known to be HIV positive, we extracted the last documented viral load value from his/her electronic chart. If no viral load was available, we requested an HIV-1 RNA viral load (HIV-1 Test, version 2.0; Roche, Branchburg). Eventually, we collected data on whether PEP was prescribed, the postgraduate education of the physician in charge, and the rational for the decision.
Risk Assessment Algorithm for PEP Decision Making
To assess the adequacy of PEP decision making, we developed an epidemiology-based risk assessment algorithm taking into account known risk factors for HIV transmission (Fig. 1) . A time lag of .72 hours between sexual exposure and ER visit renders PEP inefficient, and in these cases, PEP was not indicated. Next, we ascertained the HIV status of the source partner, either by a negative HIV test done within the past 3 months or otherwise the result of an on-the-spot HIV test. In the case of HIV infection but an HIV RNA copy number ,50/mL within the last 3 months or at presentation, we considered PEP as not indicated. The 3-month cutoff for having an HIV RNA below the detection limit is based on the 3-month intervals we see the HIV patients in our outpatient clinic, which is the standard of care. If the HIV status of the source partner was unknown, we classified the incident as low HIV transmission risk, and PEP was not indicated unless the source partner belonged to a high-risk group (Fig. 1) .
We used this algorithm to categorize the PEP decisions as concordant (ie, "prescribed-and-indicated" or "not-prescribed-and-not-indicated") or discordant ("prescribed-whilenot-indicated" or "not-prescribed-while-indicated").
numerical variables, a Mann-Whitney U test was used. We used logistic regression to estimate correlating factors with prescribing or not prescribing PEP, stratified by concordant and discordant decisions (2 models). Statistical analysis was performed with R (version 3.2.3, http://cran.r-project.org). (Fig. 2) . The median age at first visit was 31 years (IQR 26-38). Out of all visits, 872/ 1051 (83%) exposed were men, 746/1051 (71%) were Swiss, 61/1051 (5.8%) were German, 42/1051 (4%) were Italian, and 202/1051 (19.2%) were from various countries. In 393/1051 (37.4%) visits, sexual contact between men was documented.
RESULTS
Demographic Data of the Exposed Persons
A large proportion of all PEP visits (43%, 451/1051) were on weekends (Table 1) In 4/1051 (0.4%) visits, the exposed person turned out to be HIV positive already at presentation.
Condom Use and Type of Sexual Intercourse
The exposed persons reported condomless sex in 527/1051 (50.1%) visits, condom breakage or slippage (condom dysfunction) in 433/1051 (41.2%) visits, and protected sex in 23/1051 (2.2%) visits. In 68/1051 (6.5%) visits, data were missing. MSM had mainly anal sex with 320/393 (81%) incidents. The anal sex was receptive in 120/320 (37%) visits, insertive in 84/320 (26%), versatile in 15/320 (5%), and data were missing in 101/320 (32%) visits. Heterosexual men and women had mainly vaginal intercourse with 387/448 (86%) and 153/176 (86%), respectively.
Demographic Data of the Source Partners
The source partner belonged to a group at high risk of being HIV infected in 670/1051 (63.7%) visits. More FIGURE 1. HIV transmission risk assessment algorithm used for the revision of PEP prescribed in the ER. All presentations after unprotected sexual intercourse (ie, condomless sex or condom dysfunction) were retrospectively evaluated using this risk assessment algorithm.
specifically, 401/1051 (38%) were MSM, 256/1051 (24%) were sex workers, 46/1051 (4.3%) were from an HIV endemic region, and 11/1051 (1%) were IDU. The source partner belonged to more than one risk group in 41/1051 (4%) visits.
In 20% (211/1051) of the visits, the source partner did not belong to a risk group and has not presented, and his/her HIV status was unknown. This represents the fraction of lowrisk presentations.
Source partners accompanied the exposed person in 170/ 1051 (16%) of the visits. However, we observed a decline in source partner presentation from 23% (27/114) in 2007 to 11.8% (15/129) in 2013 (P for trend = 0.042). Women were twice as likely to present with the source partner than men [27.9% (50/179) vs. 13.8% (120/872), Fisher exact test, P , 0.001]. The source partner was HIV infected in 131/1051 (12%) of the visits as self-reported or documented in his/her chart at the USZ. Out of those, for 60 (60/131, 45%), we could retrieve a viral load value, 23 were documented and within last 3 months of presentation (others were either self-reported or more than 3 months old). In 65% (39/60), the viral load was suppressed (,50 copies per milliliter), and for the rest, the median viral load was 3500 (IQR 456-10,000) copies per milliliter.
We did not observe an increase in sexual intercourse with HIV-infected source partners over time (P for trend 0.48).
Revision of the PEP Decision Making
PEP was prescribed in 644/1051 (61%) visits overall ( Table 1 ). The PEP decision making of the physician in charge was in accord with the risk assessment algorithm in 779/1051 (74%) visits (ie, 485 prescribed-and-indicated and 294 not-prescribed-and-not-indicated) (Fig. 3) . In 226/1051 (22%) visits, the decision making was discordant [ie, 125/226 (55%) prescribed-while-not-indicated and 101/226 (45%) not-prescribed-while-indicated] (see Table 1 , Supplemental Digital Content, http://links.lww.com/QAI/A956).
The main reason for prescribing PEP when it was not indicated was the person's request in a low-risk situation in 76/125 (61%) visits. Although women made up only 78/644 (12%) of all prescribed PEPs, they were overrepresented with 27/76 (35%) in the category prescribed-while-not-indicated because of their request (Fisher exact test P , 0.0001). The remaining 49/125 (39%) PEPs prescribed in the category prescribed-while-not-indicated were explained by an incorrect interpretation of the sexual risk situation by physicians. Notably, in 485/644 (75%) visits, PEP was prescribed concordantly to the risk assessment algorithm.
Overall, there were 586 putative risk situations where PEP was indicated [ie, 485 prescribed-and-indicated (concordant) plus 101 not-prescribed-while-indicated (discordant)] (Fig. 3) . In these 101/586 (17%) risk situations, PEP was not prescribed because of exposed person's refusal (31/101, 31%), the physicians not following the recommendation to give PEP within the lag time of 72 hours between the sexual incident and presentation (9/101, 9%), and the physician's incorrect interpretation of the sexual risk for HIV transmission (61/101, 60%). Notably, 20/61 (33%) sexual contacts were oral, and oral sex has a lower HIV transmission risk than vaginal or anal sex, especially if there is no exchange of sperm or blood. In 2/ 20 (10%) oral sex incidents, the source partners were HIV infected and one had 10 4 HIV RNA copies per milliliter in the blood. Infectious disease (ID) specialists took the decisions in 10/20 (50%) of these oral sex-only incidents, which is significantly more often than their overall involvement in decision making [179/1051 (17%), Fisher exact test P , 0.001]. Notwithstanding, in 41/61 incidents, a high risk for HIV transmission existed. Considering a total of 407 visits in which no PEP was prescribed, these 41/407 (10%) missed opportunities represent a considerable number in the context of HIV prevention. Finally, visits in which contact with a sex worker took place were significantly overrepresented in this category of not-prescribed-while-indicated (43.6%, 44/101 vs. 22.3%, 212/950, Fisher exact test P , 0.001).
We have not observed a change in the fraction of discordant decisions with time (Fig. 2) . In the remaining 46/ 1051 (4%) visits, the data were too incomplete to categorize the decision making. The main missing variables were sex of the source partner (hence it was not clear if the exposed person belonged to the MSM risk group), condom use, and time since exposure or combination of those. 
Factors Correlating With PEP Decision Making
First, we used multivariable logistic regression to define factors that correlate with concordant decisions. Repeated visits to the ER for PEP [odds ratio (OR) 2.78; 95% confidence interval (CI): 1.54 to 5.03] and PEP decision making by ID specialists (OR 1.85; 95% CI: 1.09 to 3.12) were associated with concordant decisions on PEP prescription (ie, prescribedand-indicated) and attendance of the source partner (OR 0.05; 95% CI: 0.03 to 0.08) and female sex (OR 0.16; 95% CI: 0.10 to 0.27) with concordant decisions on nonprescription (ie, notprescribed-and-not-indicated) ( Table 2) . In a second model, we used multivariable analysis to describe factors that might lead to discordant decisions. Female sex (OR 11.38; 95% CI: 4.10 to 31.6) and visits to the ER between 06:00 AM and noon (OR 2.92; 95% CI: 1.01 to 8.42) were associated with discordant decisions (ie, prescribed-while-not-indicated). Decision making by ID specialists as opposed to residents in internal medicine was associated with the decision category not-prescribed-whileindicated (OR 0. 38; 95% CI: 0.18 to 0. 81). This association became nonsignificant when the oral sex-only visits were excluded (OR 0.47; 95% CI: 0.20 to 1.07).
DISCUSSION
Accurately estimating the risk of HIV transmission after consensual sex and determining the necessity of PEP prescription are challenges for the ER physicians. 8 Here we retrospectively examined the accuracy of PEP prescriptions using a feasible risk assessment algorithm based on epidemiological HIV transmission risk and identified factors that correlate with risk-concordant decision making. Our main findings were that (1) the ER physician estimated the sexual risk for HIV transmission correctly in most visits (74%); however, in 10% of visits, PEP was not prescribed despite a risk situation. Furthermore, 12% of all PEP prescriptions were based on the exposed person's request rather than an appropriate indication. (2) Repeated visits and ID expert opinion were factors associated with correct prescription of PEPs, whereas consultation in the morning and female sex were associated with equivocal PEP prescriptions. (3) The presence of the source partner resulted in correctly withholding PEP.
Our risk assessment algorithm is in-line with the latest EACS and FOPH guidelines and was used to retrospectively define HIV transmission risk and prescription indications. The internal USZ guidelines, relevant to the analyzed period, did not specify the risk groups, hence giving leeway to the clinician in charge and requesting a detailed knowledge about HIV transmission risk. In addition, it was stated that the subjective fears and concerns of the exposed person should be taken into account, meaning that some PEPs were prescribed on demand in low-risk situations. Here, our aim was to estimate the objective risk of HIV transmission in each situation and to define factors correlating with correct and incorrect PEP prescriptions, not to describe the rate of adherence to internal guidelines.
We found that 12% of all PEPs were prescribed based on exposed person's request (prescribed-while-not-indicated). This might be because of inadequate counseling by the ER physician, limited knowledge of HIV transmission risk among them, or exposed person's demand because of fear of contracting HIV. Notably, patient request and uncertainty by the physicians affect drug prescription habits. 15, 16 More women fell into this category; it can be hypothesized that women may be more concerned about HIV or simply look for maximum protection. 17 In addition, the gender of the physician in charge may influence the decision making, an issue not examined here. [18] [19] [20] [21] In 17% of the sexual incidents with a given risk for HIV transmission, PEP was not prescribed (not-prescribed-whileindicated). This was because of exposed person's refusal (n = 31) and physician's decision (n = 70). We speculate that balancing the actual risk of acquiring HIV against the potential side effects of PEP led to its refusal. 13, 14 A word of caution must be added about the rather high number of physician decisions against PEP prescription: oral intercourse is a lowrisk situation with an estimated HIV transmission rate of ,4/ 10,000 incidents as opposed to insertive anal intercourse with 11/10,000. [22] [23] [24] We did not include such subtle distinctions in our risk assessment algorithm as ER physicians were not specifically trained to integrate the detailed sexual history into the assessment of the HIV transmission risk. In addition, sexual history may be unreliable, and the notes in the charts are sometimes rudimentary, thus rendering them not useful for retrospective risk assessment. Finally, the local recommendations did not differentiate between sexual risks taken. That is why the ER physicians and, in particular, ID specialists might have advised against PEP after taking into account a low-risk situation (oral sex only), and this may explain the relatively high number of discordant decisions.
The presence of the source partner in the ER significantly improved the odds of concordant decision making. The immediate HIV testing of both sexual partners certainly defines the transmission risk in a best way. Importantly, current HIV tests are very sensitive and detect antigen and antibodies, 25 making it unlikely that an acute HIV infection is missed. Thus, persons seeking advice for PEP should be encouraged to present with their source partner 22 when receiving information about PEP.
Remarkably, the number of visits to our ER for PEP remained stable over the observation period. This can be explained by the interplay of the following factors. On the one hand, more risk behavior as the result of "the Swiss Statement" in 2008 that "HIV-positive persons on ART with undetectable viral loads and no other sexually transmitted infections may engage in condomless sex while in a stable relationship". [26] [27] [28] On the other hand, concern of an HIV infection may be less, leading to a smaller probability of demanding PEP when risk behavior occurred. This is backed up by recent studies showing an increase in unprotected sex in HIV-infected heterosexuals and MSM in both occasional and stable partnerships. 29 Alternatively, persons who engage in high-risk sexual activities and do not present to the ER may be ignorant about PEP and its benefit for reducing HIV transmission. 30 Indeed, knowledge of PEP was unexpectedly low (48.7%) even among HIV-infected individuals overall in the United Kingdom. 31 In Switzerland, even the long-lasting public health campaigns directed to HIV transmission prevention do not promote PEP. However, prescriptions doubled in a local gay health community center (www.mycheckpoint. ch/en/zh, Bruggmann P, MD, written personal communication 06.01.2016) in the corresponding period. For some fraction of these, the prescribed PEP might have been obtained because of a claimed but nonexistent risk situation with the intention, on the recipient's side, to use it as PrEP. We found that only 6.5% of all persons repetitively showed up at the ER for PEP. This number is substantially lower than the 20% reported in previous studies [32] [33] [34] [35] and, thus, suggests that PEP is unlikely to promote higher sexual risk behavior, which is consistent with a report by Martin et al. 36 However, persons with high-risk sexual behavior, presenting repetitively for PEP, most likely would be the ideal candidates for HIV PrEP.
In summary, PEP decision making was adequate in the majority of visits; however, in every fifth visit, it was wrong. To benefit most from PEP, we see the need for further improvement in PEP decision making and counseling. Thus, ER physicians may benefit from a specialized risk assessment training that might incorporate the use of risk assessment algorithms. On the exposed person's side, future public health campaigns could increase PEP awareness alongside with knowledge about the risk situations that justify presentation. A special emphasis can be made on the benefits of presentation together with the source partner.
